Cite

HARVARD Citation

    Sellers, J. et al. (2023). Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score. Pulmonary pharmacology & therapeutics. p. . [Online]. 
  
Back to record